<?xml version="1.0" encoding="UTF-8" ?>
			<?xml-stylesheet href="/rss/rss2html.xsl" type="text/xsl" media="screen"?>
			<rss version="2.0" xmlns:alacra="http://www.alacra.com" xmlns:bir="http://www.alacra.com/bir" xmlns:sdc="http://www.alacra.com/sdc" ><channel><title>Sopharma AD RSS Research Feed - Subscribe Today - AlacraStore.com</title>
<description>Sopharma AD</description>
<link>http://www.alacrastore.com/company-snapshot/Sopharma_AD-2516298</link>
<lastBuildDate>Sunday, September 07, 2008 1:38:37 PM</lastBuildDate>
<alacra:xlsid>2516298</alacra:xlsid>
<alacra:company>Sopharma AD</alacra:company>
<language>en</language>
<generator>AlacraStore RSS Builder 1.0</generator>
<ttl>30</ttl>
<item><title>Telso AD acquires a minority stake in Sopharma JSC</title><description>BULGARIA - Finance Consulting Co raised its stake to ##.##% from ##.##%, by acquiring a #.##% stake, or #.### mil ordinary shares, in Sopharma JSC, a Sofia-based manufacturer of pharmaceutical products, from Telso AD, in a privately negotiated transaction. Terms were not disclosed.</description><pubDate>9/4/2008 9:54:27 AM</pubDate><sdc:company_cusip xmlns:sdc="http://www.alacra.com/sdc">86646X</sdc:company_cusip><sdc:target_company_cusip xmlns:sdc="http://www.alacra.com/sdc">83584J</sdc:target_company_cusip><sdc:company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">86646X</sdc:company_cusip_up><sdc:target_company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">83584J</sdc:target_company_cusip_up><sdc:company xmlns:sdc="http://www.alacra.com/sdc">Telso AD</sdc:company><sdc:target_company xmlns:sdc="http://www.alacra.com/sdc">Sopharma JSC</sdc:target_company><sdc:company_up xmlns:sdc="http://www.alacra.com/sdc">Telso AD</sdc:company_up><sdc:target_company_up xmlns:sdc="http://www.alacra.com/sdc">Sopharma JSC</sdc:target_company_up><link>http://www.alacrastore.com/storecontent/Thomson_M%26A/Telso_AD_acquires_a_minority_stake_in_Sopharma_JSC-2009057040</link><guid isPermaLink="false">sdc/2009057040</guid><sdc:deal xmlns:sdc="http://www.alacra.com/sdc"><sdc:deal_no>2009057040</sdc:deal_no><sdc:_copyright><sdc:value>Copyright Â© 2008, Thomson Financial, All Rights Reserved</sdc:value></sdc:_copyright><sdc:a_MAINDUSTRY><sdc:value>Drugs</sdc:value></sdc:a_MAINDUSTRY><sdc:a_NATION><sdc:value>Bulgaria</sdc:value></sdc:a_NATION><sdc:a_SICDESC><sdc:value>Pharmaceutical preparations</sdc:value></sdc:a_SICDESC><sdc:a_SICPI><sdc:value>2834</sdc:value></sdc:a_SICPI><sdc:a_STATE><sdc:value>FF</sdc:value></sdc:a_STATE><sdc:a_STATELONG><sdc:value>Foreign</sdc:value></sdc:a_STATELONG><sdc:a_STATUS><sdc:value>Private</sdc:value></sdc:a_STATUS><sdc:asic_SIC><sdc:value sdc:p="0">2833:Medicinal chemicals and botanical products</sdc:value><sdc:value sdc:p="1">2834:Pharmaceutical preparations</sdc:value><sdc:value sdc:p="2">2836:Biological products, except diagnostic substances</sdc:value></sdc:asic_SIC><sdc:aupsic_SIC><sdc:value sdc:p="0">2833:Medicinal chemicals and botanical products</sdc:value><sdc:value sdc:p="1">2834:Pharmaceutical preparations</sdc:value><sdc:value sdc:p="2">2836:Biological products, except diagnostic substances</sdc:value></sdc:aupsic_SIC><sdc:b_EXCHANGE><sdc:value>Sofia</sdc:value></sdc:b_EXCHANGE><sdc:b_MAINDUSTRY><sdc:value>Drugs</sdc:value></sdc:b_MAINDUSTRY><sdc:b_NATION><sdc:value>Bulgaria</sdc:value></sdc:b_NATION><sdc:b_SICDESC><sdc:value>Pharmaceutical preparations</sdc:value></sdc:b_SICDESC><sdc:b_SICPI><sdc:value>2834</sdc:value></sdc:b_SICPI><sdc:b_STATE><sdc:value>FF</sdc:value></sdc:b_STATE><sdc:b_STATELONG><sdc:value>Foreign</sdc:value></sdc:b_STATELONG><sdc:b_STATUS><sdc:value>Public</sdc:value></sdc:b_STATUS><sdc:b_TICKER><sdc:value>SFARM</sdc:value></sdc:b_TICKER><sdc:c_ACIDGEN><sdc:value>1034646001</sdc:value></sdc:c_ACIDGEN><sdc:c2up_BUSS><sdc:value>Mnfr pharm prod</sdc:value></sdc:c2up_BUSS><sdc:c3up_BUSS><sdc:value>Mnfr pharm prod</sdc:value></sdc:c3up_BUSS><sdc:co_DESCR><sdc:value>Unspecified</sdc:value></sdc:co_DESCR><sdc:cs_DESCR><sdc:value>Ordinary Share</sdc:value></sdc:cs_DESCR><sdc:d_TCIDGEN><sdc:value>540804003</sdc:value></sdc:d_TCIDGEN><sdc:date_lastupdate><sdc:value>Sep 4 2008</sdc:value></sdc:date_lastupdate><sdc:finbltm_BV><sdc:value>0.00000</sdc:value></sdc:finbltm_BV><sdc:finbltm_CASH><sdc:value>0.00000</sdc:value></sdc:finbltm_CASH><sdc:finbltm_CASHFLOW><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW><sdc:finbltm_CASHFLOW1><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW1><sdc:finbltm_CASHFLOW2><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW2><sdc:finbltm_CASHFLOW3><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW3><sdc:finbltm_CASHFLOW4><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW4><sdc:finbltm_CASHFLOW5><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW5><sdc:finbltm_COMEQ><sdc:value>0.00000</sdc:value></sdc:finbltm_COMEQ><sdc:finbltm_DEBTRAT><sdc:value>0.00000</sdc:value></sdc:finbltm_DEBTRAT><sdc:finbltm_DSER2><sdc:value>0.00000</sdc:value></sdc:finbltm_DSER2><sdc:finbltm_EBIT><sdc:value>0.00000</sdc:value></sdc:finbltm_EBIT><sdc:finbltm_EPS><sdc:value>0.00000</sdc:value></sdc:finbltm_EPS><sdc:finbltm_NI><sdc:value>0.00000</sdc:value></sdc:finbltm_NI><sdc:finbltm_PTINC><sdc:value>0.00000</sdc:value></sdc:finbltm_PTINC><sdc:finbltm_SALES><sdc:value>0.00000</sdc:value></sdc:finbltm_SALES><sdc:finbltm_STDEBT><sdc:value>0.00000</sdc:value></sdc:finbltm_STDEBT><sdc:finbltm_TASS><sdc:value>0.00000</sdc:value></sdc:finbltm_TASS><sdc:fiscal_ADCR><sdc:value>0.00000</sdc:value></sdc:fiscal_ADCR><sdc:fiscal_ANI><sdc:value>0.00000</sdc:value></sdc:fiscal_ANI><sdc:fiscal_APFDCR><sdc:value>0.00000</sdc:value></sdc:fiscal_APFDCR><sdc:fiscal_ASALES><sdc:value>0.00000</sdc:value></sdc:fiscal_ASALES><sdc:fiscal_ATASS><sdc:value>0.00000</sdc:value></sdc:fiscal_ATASS><sdc:fiscal_RATE><sdc:value>0.00000</sdc:value></sdc:fiscal_RATE><sdc:g_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value></sdc:g_SEQ><sdc:g_TEST><sdc:value sdc:p="0">Telso AD, based in Bulgaria,</sdc:value><sdc:value sdc:p="1">manufactures pharmaceutical</sdc:value><sdc:value sdc:p="2">products.</sdc:value></sdc:g_TEST><sdc:g_business><sdc:value sdc:p="0">Telso AD, based in Bulgaria, manufactures pharmaceutical</sdc:value><sdc:value sdc:p="1">products.</sdc:value></sdc:g_business><sdc:g_business1><sdc:value>Telso AD, based in Bulgaria, manufactures pharmaceutical products.</sdc:value></sdc:g_business1><sdc:h_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value></sdc:h_SEQ><sdc:h_TEST><sdc:value sdc:p="0">Sopharma JSC, located in</sdc:value><sdc:value sdc:p="1">Sofia, Bulgaria, manufactures</sdc:value><sdc:value sdc:p="2">pharmaceutical products</sdc:value><sdc:value sdc:p="3">including solutions for</sdc:value><sdc:value sdc:p="4">hemodialysis, diagnostics,</sdc:value><sdc:value sdc:p="5">solution for lenses, food</sdc:value><sdc:value sdc:p="6">supplements, cosmetic products</sdc:value><sdc:value sdc:p="7">and solutions for mouth</sdc:value><sdc:value sdc:p="8">cavity. The company was</sdc:value><sdc:value sdc:p="9">founded in 1942.</sdc:value></sdc:h_TEST><sdc:h_business><sdc:value sdc:p="0">Sopharma JSC, located in Sofia, Bulgaria, manufactures</sdc:value><sdc:value sdc:p="1">pharmaceutical products including solutions for</sdc:value><sdc:value sdc:p="2">hemodialysis, diagnostics, solution for lenses, food</sdc:value><sdc:value sdc:p="3">supplements, cosmetic products and solutions for mouth</sdc:value><sdc:value sdc:p="4">cavity. The company was founded in 1942.</sdc:value></sdc:h_business><sdc:h_business1><sdc:value>Sopharma JSC, located in Sofia, Bulgaria, manufactures pharmaceutical products including solutions for hemodialysis, diagnostics, solution for lenses, food supplements, cosmetic products and solutions for mouth cavity. The company was founded in 1942.</sdc:value></sdc:h_business1><sdc:i_AFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_AFEEPCT><sdc:i_AFEETOT><sdc:value>0.00000</sdc:value></sdc:i_AFEETOT><sdc:i_ATERMFEE><sdc:value>0.00000</sdc:value></sdc:i_ATERMFEE><sdc:i_COMOUT><sdc:value>132.00000</sdc:value></sdc:i_COMOUT><sdc:i_CROSS1><sdc:value>N</sdc:value></sdc:i_CROSS1><sdc:i_DATEANN><sdc:value>02 Sep 08</sdc:value></sdc:i_DATEANN><sdc:i_DATEANN2><sdc:value>Tue, 02 Sep 2008 00:00:00 EST</sdc:value></sdc:i_DATEANN2><sdc:i_DATEANNS><sdc:value>Date Announced: 09/02/2008</sdc:value></sdc:i_DATEANNS><sdc:i_DATEEFF><sdc:value>02 Sep 08</sdc:value></sdc:i_DATEEFF><sdc:i_DATEEFFS><sdc:value>Date Effective: 09/02/2008</sdc:value></sdc:i_DATEEFFS><sdc:i_DATEUNCON><sdc:value>02 Sep 08</sdc:value></sdc:i_DATEUNCON><sdc:i_DESCR><sdc:value>Acq. Part. Int.</sdc:value></sdc:i_DESCR><sdc:i_DESCR1><sdc:value>Neutral</sdc:value></sdc:i_DESCR1><sdc:i_FEEPCT><sdc:value>0.00000</sdc:value></sdc:i_FEEPCT><sdc:i_FEETOT><sdc:value>0.00000</sdc:value></sdc:i_FEETOT><sdc:i_HOSTAFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTAFEETOT><sdc:i_HOSTENTVAL><sdc:value>0.00000</sdc:value></sdc:i_HOSTENTVAL><sdc:i_HOSTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTFEETOT><sdc:i_HOSTPR><sdc:value>0.00000</sdc:value></sdc:i_HOSTPR><sdc:i_HOSTPRLABEL><sdc:value>Price/Share</sdc:value></sdc:i_HOSTPRLABEL><sdc:i_HOSTTFEETOT><sdc:value>0.00000</sdc:value></sdc:i_HOSTTFEETOT><sdc:i_HOSTVALUE><sdc:value>0</sdc:value></sdc:i_HOSTVALUE><sdc:i_HOSTVALUE1><sdc:value>0.00000</sdc:value></sdc:i_HOSTVALUE1><sdc:i_HOST_EQVAL><sdc:value>0.00000</sdc:value></sdc:i_HOST_EQVAL><sdc:i_HOST_RANKVAL><sdc:value>0</sdc:value></sdc:i_HOST_RANKVAL><sdc:i_HOST_RANKVAL1><sdc:value>0.00000</sdc:value></sdc:i_HOST_RANKVAL1><sdc:i_PCTACQ><sdc:value>6.76000</sdc:value></sdc:i_PCTACQ><sdc:i_PCTOWN><sdc:value>16.79000</sdc:value></sdc:i_PCTOWN><sdc:i_PR><sdc:value>0.00000</sdc:value></sdc:i_PR><sdc:i_PR_INITIAL><sdc:value>0.00000</sdc:value></sdc:i_PR_INITIAL><sdc:i_RANKVAL><sdc:value>0.00000</sdc:value></sdc:i_RANKVAL><sdc:i_RANK_HOSTRANKVAL><sdc:value>0</sdc:value></sdc:i_RANK_HOSTRANKVAL><sdc:i_RATE><sdc:value>0.00000</sdc:value></sdc:i_RATE><sdc:i_STATUS_MMC><sdc:value>N</sdc:value></sdc:i_STATUS_MMC><sdc:i_STGVAL><sdc:value>0.00000</sdc:value></sdc:i_STGVAL><sdc:i_TERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TERMFEE><sdc:i_TFEEPCT><sdc:value>0.00000</sdc:value></sdc:i_TFEEPCT><sdc:i_TFEETOT><sdc:value>0.00000</sdc:value></sdc:i_TFEETOT><sdc:i_TTERMFEE><sdc:value>0.00000</sdc:value></sdc:i_TTERMFEE><sdc:i_VALLIA><sdc:value>0.00000</sdc:value></sdc:i_VALLIA><sdc:i_VALNOLIA><sdc:value>0.00000</sdc:value></sdc:i_VALNOLIA><sdc:i_VALUE><sdc:value>0.00000</sdc:value></sdc:i_VALUE><sdc:j_EQVALCF><sdc:value>0.00000</sdc:value></sdc:j_EQVALCF><sdc:j_EVCF><sdc:value>0.00000</sdc:value></sdc:j_EVCF><sdc:j_EVEBIT><sdc:value>0.00000</sdc:value></sdc:j_EVEBIT><sdc:j_EVNI><sdc:value>0.00000</sdc:value></sdc:j_EVNI><sdc:j_EVSALES><sdc:value>0.00000</sdc:value></sdc:j_EVSALES><sdc:j_MPRICEBOOK><sdc:value>0.00000</sdc:value></sdc:j_MPRICEBOOK><sdc:j_PHELD><sdc:value>10.03000</sdc:value></sdc:j_PHELD><sdc:j_PSOUGHT><sdc:value>6.76000</sdc:value></sdc:j_PSOUGHT><sdc:j_RANKVALCF><sdc:value>0.00000</sdc:value></sdc:j_RANKVALCF><sdc:j_RANKVALEB><sdc:value>0.00000</sdc:value></sdc:j_RANKVALEB><sdc:j_RANKVALNA><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNA><sdc:j_RANKVALNI><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNI><sdc:j_RANKVALSALES><sdc:value>0.00000</sdc:value></sdc:j_RANKVALSALES><sdc:j_VALEB><sdc:value>0.00000</sdc:value></sdc:j_VALEB><sdc:j_VALNI><sdc:value>0.00000</sdc:value></sdc:j_VALNI><sdc:j_VALSALES><sdc:value>0.00000</sdc:value></sdc:j_VALSALES><sdc:m_AMV><sdc:value>0.00000</sdc:value></sdc:m_AMV><sdc:m_CF3YGR><sdc:value>0.00000</sdc:value></sdc:m_CF3YGR><sdc:m_CF5YGR><sdc:value>0.00000</sdc:value></sdc:m_CF5YGR><sdc:m_DCR><sdc:value>0.00000</sdc:value></sdc:m_DCR><sdc:m_ENTVAL><sdc:value>0.00000</sdc:value></sdc:m_ENTVAL><sdc:m_EPS3YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS3YGR><sdc:m_EPS5YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS5YGR><sdc:m_LTD><sdc:value>0.00000</sdc:value></sdc:m_LTD><sdc:m_MV><sdc:value>0.00000</sdc:value></sdc:m_MV><sdc:m_NETASS><sdc:value>0.00000</sdc:value></sdc:m_NETASS><sdc:m_NETASS3YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS3YGR><sdc:m_NETASS5YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS5YGR><sdc:m_NI3YGR><sdc:value>0.00000</sdc:value></sdc:m_NI3YGR><sdc:m_NI5YGR><sdc:value>0.00000</sdc:value></sdc:m_NI5YGR><sdc:n_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value><sdc:value sdc:p="10">11.00000</sdc:value></sdc:n_SEQ><sdc:n_SYNOPSIS><sdc:value sdc:p="0">BULGARIA - Finance Consulting</sdc:value><sdc:value sdc:p="1">Co raised its stake to 16.79%</sdc:value><sdc:value sdc:p="2">from 10.03%, by acquiring a</sdc:value><sdc:value sdc:p="3">6.76% stake, or 8.923 mil</sdc:value><sdc:value sdc:p="4">ordinary shares, in Sopharma</sdc:value><sdc:value sdc:p="5">JSC, a Sofia-based</sdc:value><sdc:value sdc:p="6">manufacturer of pharmaceutical</sdc:value><sdc:value sdc:p="7">products, from Telso AD, in a</sdc:value><sdc:value sdc:p="8">privately negotiated</sdc:value><sdc:value sdc:p="9">transaction. Terms were not</sdc:value><sdc:value sdc:p="10">disclosed.</sdc:value></sdc:n_SYNOPSIS><sdc:n_synopsis2><sdc:value>BULGARIA - Finance Consulting Co raised its stake to 16.79% from 10.03%, by acquiring a 6.76% stake, or 8.923 mil ordinary shares, in Sopharma JSC, a Sofia-based manufacturer of pharmaceutical products, from Telso AD, in a privately negotiated transaction. Terms were not disclosed.</sdc:value></sdc:n_synopsis2><sdc:n_synopsis3><sdc:value sdc:p="0">BULGARIA - Finance Consulting Co raised its stake to 16.79% from 10.03%, by acquiring a</sdc:value><sdc:value sdc:p="1">6.76% stake, or 8.923 mil ordinary shares, in Sopharma JSC, a Sofia-based manufacturer of</sdc:value><sdc:value sdc:p="2">pharmaceutical products, from Telso AD, in a privately negotiated transaction. Terms were</sdc:value><sdc:value sdc:p="3">not disclosed.</sdc:value></sdc:n_synopsis3><sdc:n_synopsis4><sdc:value sdc:p="0">BULGARIA - Finance Consulting Co raised its stake to 16.79% from 10.03%, by acquiring a 6.76% stake, or 8.923 mil ordinary shares, in Sopharma JSC, a Sofia-based manufacturer of pharmaceutical</sdc:value><sdc:value sdc:p="1">products, from Telso AD, in a privately negotiated transaction. Terms were not disclosed.</sdc:value></sdc:n_synopsis4><sdc:n_synopsis5><sdc:value sdc:p="0">BULGARIA - Finance Consulting Co raised its stake to 16.79% from 10.03%, by acquiring a 6.76% stake, or 8.923 mil ordinary shares, in</sdc:value><sdc:value sdc:p="1">Sopharma JSC, a Sofia-based manufacturer of pharmaceutical products, from Telso AD, in a privately negotiated transaction. Terms were not</sdc:value><sdc:value sdc:p="2">disclosed.</sdc:value></sdc:n_synopsis5><sdc:q_DESCR><sdc:value>Completed</sdc:value></sdc:q_DESCR><sdc:q_HOSTANETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTANETASS><sdc:q_HOSTANILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTANILTM><sdc:q_HOSTASALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTASALESLTM><sdc:q_HOSTATASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTATASS><sdc:q_HOSTBOOKVALUE><sdc:value>0.00000</sdc:value></sdc:q_HOSTBOOKVALUE><sdc:q_HOSTCASHFLOW><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW><sdc:q_HOSTCASHFLOW1><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW1><sdc:q_HOSTCASHFLOW2><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW2><sdc:q_HOSTCASHFLOW3><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW3><sdc:q_HOSTCASHFLOW4><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW4><sdc:q_HOSTCASHFLOW5><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW5><sdc:q_HOSTCOMMONEQUITY><sdc:value>0.00000</sdc:value></sdc:q_HOSTCOMMONEQUITY><sdc:q_HOSTEBITLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEBITLTM><sdc:q_HOSTEPS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS1><sdc:q_HOSTEPS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS2><sdc:q_HOSTEPS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS3><sdc:q_HOSTEPS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS4><sdc:q_HOSTEPS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS5><sdc:q_HOSTEPSLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPSLTM><sdc:q_HOSTNETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS><sdc:q_HOSTNETASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS1><sdc:q_HOSTNETASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS2><sdc:q_HOSTNETASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS3><sdc:q_HOSTNETASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS4><sdc:q_HOSTNETASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS5><sdc:q_HOSTNI1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI1><sdc:q_HOSTNI2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI2><sdc:q_HOSTNI3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI3><sdc:q_HOSTNI4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI4><sdc:q_HOSTNI5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI5><sdc:q_HOSTNILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTNILTM><sdc:q_HOSTPTINC1><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC1><sdc:q_HOSTPTINC2><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC2><sdc:q_HOSTPTINC3><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC3><sdc:q_HOSTPTINC4><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC4><sdc:q_HOSTPTINC5><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC5><sdc:q_HOSTPTINCLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINCLTM><sdc:q_HOSTSALES1><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES1><sdc:q_HOSTSALES2><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES2><sdc:q_HOSTSALES3><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES3><sdc:q_HOSTSALES4><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES4><sdc:q_HOSTSALES5><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES5><sdc:q_HOSTSALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALESLTM><sdc:q_HOSTTASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS><sdc:q_HOSTTASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS1><sdc:q_HOSTTASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS2><sdc:q_HOSTTASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS3><sdc:q_HOSTTASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS4><sdc:q_HOSTTASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS5><sdc:q_STATUS><sdc:value>Status:Completed</sdc:value></sdc:q_STATUS><sdc:r_PE><sdc:value>-999.00000</sdc:value></sdc:r_PE><sdc:r_PE_PRINT><sdc:value>np</sdc:value></sdc:r_PE_PRINT><sdc:r_PFTMARG><sdc:value>0.00000</sdc:value></sdc:r_PFTMARG><sdc:r_PRICEBOOK><sdc:value>-999.00000</sdc:value></sdc:r_PRICEBOOK><sdc:r_PRICEBOOK_PRINT><sdc:value>np</sdc:value></sdc:r_PRICEBOOK_PRINT><sdc:r_PTINC3YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC3YGR><sdc:r_PTINC5YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC5YGR><sdc:r_ROE><sdc:value>0.00000</sdc:value></sdc:r_ROE><sdc:r_SALES3YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES3YGR><sdc:r_SALES5YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES5YGR><sdc:r_SE><sdc:value>0.00000</sdc:value></sdc:r_SE><sdc:r_TASS3YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS3YGR><sdc:r_TASS5YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS5YGR><sdc:r_TTCFMULT><sdc:value>0.00000</sdc:value></sdc:r_TTCFMULT><sdc:r_TTEBITMULT><sdc:value>0.00000</sdc:value></sdc:r_TTEBITMULT><sdc:r_VALNA><sdc:value>0.00000</sdc:value></sdc:r_VALNA><sdc:sic_SIC><sdc:value sdc:p="0">2833:Medicinal chemicals and botanical products</sdc:value><sdc:value sdc:p="1">2834:Pharmaceutical preparations</sdc:value><sdc:value sdc:p="2">2836:Biological products, except diagnostic substances</sdc:value></sdc:sic_SIC><sdc:upa_UPACIDGEN><sdc:value>1034646001</sdc:value></sdc:upa_UPACIDGEN><sdc:upa1_NATION><sdc:value>Bulgaria</sdc:value></sdc:upa1_NATION><sdc:upa1_SICP><sdc:value>2834</sdc:value></sdc:upa1_SICP><sdc:upa1_STATE><sdc:value>Foreign</sdc:value></sdc:upa1_STATE><sdc:upa1_STATUS><sdc:value>Private</sdc:value></sdc:upa1_STATUS><sdc:upsic_SIC><sdc:value sdc:p="0">2833:Medicinal chemicals and botanical products</sdc:value><sdc:value sdc:p="1">2834:Pharmaceutical preparations</sdc:value><sdc:value sdc:p="2">2836:Biological products, except diagnostic substances</sdc:value></sdc:upsic_SIC><sdc:upt_UPTCIDGEN><sdc:value>540804003</sdc:value></sdc:upt_UPTCIDGEN><sdc:upt1_EXCHANGE><sdc:value>Sofia</sdc:value></sdc:upt1_EXCHANGE><sdc:upt1_NATION><sdc:value>Bulgaria</sdc:value></sdc:upt1_NATION><sdc:upt1_SICP><sdc:value>2834</sdc:value></sdc:upt1_SICP><sdc:upt1_STATE><sdc:value>Foreign</sdc:value></sdc:upt1_STATE><sdc:upt1_STATUS><sdc:value>Public</sdc:value></sdc:upt1_STATUS><sdc:upt1_TICKER><sdc:value>SFARM</sdc:value></sdc:upt1_TICKER><sdc:x_RANK1_VALUE><sdc:value>0.00000</sdc:value></sdc:x_RANK1_VALUE><sdc:x_RANK_HOSTRANKVAL><sdc:value>0.00000</sdc:value></sdc:x_RANK_HOSTRANKVAL><sdc:x_RANK_RANKVAL><sdc:value>0.00000</sdc:value></sdc:x_RANK_RANKVAL><sdc:x_rank_rankstgval><sdc:value>0.00000</sdc:value></sdc:x_rank_rankstgval></sdc:deal><category>Deal Information</category><alacra:ip>Thomson Financial Mergers &amp; Acquisitions</alacra:ip></item><item><title>Finance Consulting Co acquires a minority stake in Sopharma JSC</title><description>BULGARIA - Finance Consulting Co acquired a ##% stake, or ##.# mil ordinary shares, in Sopharma JSC, a Sofia-based manufacturer of pharmaceutical products, from Telso AD, in an open market transaction. Terms were not disclosed.</description><pubDate>8/15/2008 10:42:05 AM</pubDate><sdc:company_cusip xmlns:sdc="http://www.alacra.com/sdc">51289C</sdc:company_cusip><sdc:target_company_cusip xmlns:sdc="http://www.alacra.com/sdc">83584J</sdc:target_company_cusip><sdc:company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">51289C</sdc:company_cusip_up><sdc:target_company_cusip_up xmlns:sdc="http://www.alacra.com/sdc">83584J</sdc:target_company_cusip_up><sdc:company xmlns:sdc="http://www.alacra.com/sdc">Finance Consulting Co</sdc:company><sdc:target_company xmlns:sdc="http://www.alacra.com/sdc">Sopharma JSC</sdc:target_company><sdc:company_up xmlns:sdc="http://www.alacra.com/sdc">Finance Consulting Co</sdc:company_up><sdc:target_company_up xmlns:sdc="http://www.alacra.com/sdc">Sopharma JSC</sdc:target_company_up><link>http://www.alacrastore.com/storecontent/Thomson_M%26A/Finance_Consulting_Co_acquires_a_minority_stake_in_Sopharma_JSC-2004407040</link><guid isPermaLink="false">sdc/2004407040</guid><sdc:deal xmlns:sdc="http://www.alacra.com/sdc"><sdc:deal_no>2004407040</sdc:deal_no><sdc:_copyright><sdc:value>Copyright Â© 2008, Thomson Financial, All Rights Reserved</sdc:value></sdc:_copyright><sdc:a_MAINDUSTRY><sdc:value>Investment &amp; Commodity Firms,Dealers,Exchanges</sdc:value></sdc:a_MAINDUSTRY><sdc:a_NATION><sdc:value>Bulgaria</sdc:value></sdc:a_NATION><sdc:a_SICDESC><sdc:value>Investment advice</sdc:value></sdc:a_SICDESC><sdc:a_SICPI><sdc:value>6282</sdc:value></sdc:a_SICPI><sdc:a_STATE><sdc:value>FF</sdc:value></sdc:a_STATE><sdc:a_STATELONG><sdc:value>Foreign</sdc:value></sdc:a_STATELONG><sdc:a_STATUS><sdc:value>Private</sdc:value></sdc:a_STATUS><sdc:asic_SIC><sdc:value>6282:Investment advice</sdc:value></sdc:asic_SIC><sdc:aupsic_SIC><sdc:value>6282:Investment advice</sdc:value></sdc:aupsic_SIC><sdc:b_EXCHANGE><sdc:value>Sofia</sdc:value></sdc:b_EXCHANGE><sdc:b_MAINDUSTRY><sdc:value>Drugs</sdc:value></sdc:b_MAINDUSTRY><sdc:b_NATION><sdc:value>Bulgaria</sdc:value></sdc:b_NATION><sdc:b_SICDESC><sdc:value>Pharmaceutical preparations</sdc:value></sdc:b_SICDESC><sdc:b_SICPI><sdc:value>2834</sdc:value></sdc:b_SICPI><sdc:b_STATE><sdc:value>FF</sdc:value></sdc:b_STATE><sdc:b_STATELONG><sdc:value>Foreign</sdc:value></sdc:b_STATELONG><sdc:b_STATUS><sdc:value>Public</sdc:value></sdc:b_STATUS><sdc:b_TICKER><sdc:value>SFARM</sdc:value></sdc:b_TICKER><sdc:c_ACIDGEN><sdc:value>75013001</sdc:value></sdc:c_ACIDGEN><sdc:c2up_BUSS><sdc:value>Pvd finl svcs</sdc:value></sdc:c2up_BUSS><sdc:c3up_BUSS><sdc:value>Mnfr pharm prod</sdc:value></sdc:c3up_BUSS><sdc:co_DESCR><sdc:value>Unspecified</sdc:value></sdc:co_DESCR><sdc:cs_DESCR><sdc:value>Ordinary Share</sdc:value></sdc:cs_DESCR><sdc:d_TCIDGEN><sdc:value>540804003</sdc:value></sdc:d_TCIDGEN><sdc:date_lastupdate><sdc:value>Aug 15 2008</sdc:value></sdc:date_lastupdate><sdc:finbltm_BV><sdc:value>0.00000</sdc:value></sdc:finbltm_BV><sdc:finbltm_CASH><sdc:value>0.00000</sdc:value></sdc:finbltm_CASH><sdc:finbltm_CASHFLOW><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW><sdc:finbltm_CASHFLOW1><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW1><sdc:finbltm_CASHFLOW2><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW2><sdc:finbltm_CASHFLOW3><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW3><sdc:finbltm_CASHFLOW4><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW4><sdc:finbltm_CASHFLOW5><sdc:value>0.00000</sdc:value></sdc:finbltm_CASHFLOW5><sdc:finbltm_COMEQ><sdc:value>0.00000</sdc:value></sdc:finbltm_COMEQ><sdc:finbltm_DEBTRAT><sdc:value>0.00000</sdc:value></sdc:finbltm_DEBTRAT><sdc:finbltm_DSER2><sdc:value>0.00000</sdc:value></sdc:finbltm_DSER2><sdc:finbltm_EBIT><sdc:value>0.00000</sdc:value></sdc:finbltm_EBIT><sdc:finbltm_EPS><sdc:value>0.00000</sdc:value></sdc:finbltm_EPS><sdc:finbltm_NI><sdc:value>0.00000</sdc:value></sdc:finbltm_NI><sdc:finbltm_PTINC><sdc:value>0.00000</sdc:value></sdc:finbltm_PTINC><sdc:finbltm_SALES><sdc:value>0.00000</sdc:value></sdc:finbltm_SALES><sdc:finbltm_STDEBT><sdc:value>0.00000</sdc:value></sdc:finbltm_STDEBT><sdc:finbltm_TASS><sdc:value>0.00000</sdc:value></sdc:finbltm_TASS><sdc:fiscal_ADCR><sdc:value>0.00000</sdc:value></sdc:fiscal_ADCR><sdc:fiscal_ANI><sdc:value>0.00000</sdc:value></sdc:fiscal_ANI><sdc:fiscal_APFDCR><sdc:value>0.00000</sdc:value></sdc:fiscal_APFDCR><sdc:fiscal_ASALES><sdc:value>0.00000</sdc:value></sdc:fiscal_ASALES><sdc:fiscal_ATASS><sdc:value>0.00000</sdc:value></sdc:fiscal_ATASS><sdc:fiscal_RATE><sdc:value>0.00000</sdc:value></sdc:fiscal_RATE><sdc:g_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value></sdc:g_SEQ><sdc:g_TEST><sdc:value sdc:p="0">Finance Consulting Co provides</sdc:value><sdc:value sdc:p="1">financial services.</sdc:value></sdc:g_TEST><sdc:g_business><sdc:value>Finance Consulting Co provides financial services.</sdc:value></sdc:g_business><sdc:g_business1><sdc:value>Finance Consulting Co provides financial services.</sdc:value></sdc:g_business1><sdc:h_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value><sdc:value sdc:p="8">9.00000</sdc:value><sdc:value sdc:p="9">10.00000</sdc:value></sdc:h_SEQ><sdc:h_TEST><sdc:value sdc:p="0">Sopharma JSC, located in</sdc:value><sdc:value sdc:p="1">Sofia, Bulgaria, manufactures</sdc:value><sdc:value sdc:p="2">pharmaceutical products</sdc:value><sdc:value sdc:p="3">including solutions for</sdc:value><sdc:value sdc:p="4">hemodialysis, diagnostics,</sdc:value><sdc:value sdc:p="5">solution for lenses, food</sdc:value><sdc:value sdc:p="6">supplements, cosmetic products</sdc:value><sdc:value sdc:p="7">and solutions for mouth</sdc:value><sdc:value sdc:p="8">cavity. The company was</sdc:value><sdc:value sdc:p="9">founded in 1942.</sdc:value></sdc:h_TEST><sdc:h_business><sdc:value sdc:p="0">Sopharma JSC, located in Sofia, Bulgaria, manufactures</sdc:value><sdc:value sdc:p="1">pharmaceutical products including solutions for</sdc:value><sdc:value sdc:p="2">hemodialysis, diagnostics, solution for lenses, food</sdc:value><sdc:value sdc:p="3">supplements, cosmetic products and solutions for mouth</sdc:value><sdc:value sdc:p="4">cavity. The company was founded in 1942.</sdc:value></sdc:h_business><sdc:h_business1><sdc:value>Sopharma JSC, located in Sofia, Bulgaria, manufactures pharmaceutical products including solutions for hemodialysis, diagnostics, solution for lenses, food supplements, cosmetic products and solutions for mouth cavity. The company was founded in 1942.</sdc:value></sdc:h_business1><sdc:i_AFEEPCT><sdc:value>100.00000</sdc:value></sdc:i_AFEEPCT><sdc:i_AFEETOT><sdc:value>1.00000</sdc:value></sdc:i_AFEETOT><sdc:i_ATERMFEE><sdc:value>1.00000</sdc:value></sdc:i_ATERMFEE><sdc:i_COMOUT><sdc:value>132.00000</sdc:value></sdc:i_COMOUT><sdc:i_CROSS1><sdc:value>N</sdc:value></sdc:i_CROSS1><sdc:i_DATEANN><sdc:value>13 Aug 08</sdc:value></sdc:i_DATEANN><sdc:i_DATEANN2><sdc:value>Wed, 13 Aug 2008 00:00:00 EST</sdc:value></sdc:i_DATEANN2><sdc:i_DATEANNS><sdc:value>Date Announced: 08/13/2008</sdc:value></sdc:i_DATEANNS><sdc:i_DATEEFF><sdc:value>13 Aug 08</sdc:value></sdc:i_DATEEFF><sdc:i_DATEEFFS><sdc:value>Date Effective: 08/13/2008</sdc:value></sdc:i_DATEEFFS><sdc:i_DATEUNCON><sdc:value>13 Aug 08</sdc:value></sdc:i_DATEUNCON><sdc:i_DESCR><sdc:value>Acq. Part. Int.</sdc:value></sdc:i_DESCR><sdc:i_DESCR1><sdc:value>Neutral</sdc:value></sdc:i_DESCR1><sdc:i_FEEPCT><sdc:value>100.00000</sdc:value></sdc:i_FEEPCT><sdc:i_FEETOT><sdc:value>1.00000</sdc:value></sdc:i_FEETOT><sdc:i_HOSTAFEETOT><sdc:value>1.00000</sdc:value></sdc:i_HOSTAFEETOT><sdc:i_HOSTENTVAL><sdc:value>0.00000</sdc:value></sdc:i_HOSTENTVAL><sdc:i_HOSTFEETOT><sdc:value>1.00000</sdc:value></sdc:i_HOSTFEETOT><sdc:i_HOSTPR><sdc:value>1.00000</sdc:value></sdc:i_HOSTPR><sdc:i_HOSTPRLABEL><sdc:value>Price/Share</sdc:value></sdc:i_HOSTPRLABEL><sdc:i_HOSTTFEETOT><sdc:value>1.00000</sdc:value></sdc:i_HOSTTFEETOT><sdc:i_HOSTVALUE><sdc:value>1</sdc:value></sdc:i_HOSTVALUE><sdc:i_HOSTVALUE1><sdc:value>1.00000</sdc:value></sdc:i_HOSTVALUE1><sdc:i_HOST_EQVAL><sdc:value>1.00000</sdc:value></sdc:i_HOST_EQVAL><sdc:i_HOST_RANKVAL><sdc:value>1</sdc:value></sdc:i_HOST_RANKVAL><sdc:i_HOST_RANKVAL1><sdc:value>1.00000</sdc:value></sdc:i_HOST_RANKVAL1><sdc:i_PCTACQ><sdc:value>10.00000</sdc:value></sdc:i_PCTACQ><sdc:i_PCTOWN><sdc:value>10.00000</sdc:value></sdc:i_PCTOWN><sdc:i_PR><sdc:value>1.00000</sdc:value></sdc:i_PR><sdc:i_PR_INITIAL><sdc:value>1.00000</sdc:value></sdc:i_PR_INITIAL><sdc:i_RANKVAL><sdc:value>0.00000</sdc:value></sdc:i_RANKVAL><sdc:i_RANK_HOSTRANKVAL><sdc:value>1</sdc:value></sdc:i_RANK_HOSTRANKVAL><sdc:i_RATE><sdc:value>1.00000</sdc:value></sdc:i_RATE><sdc:i_STATUS_MMC><sdc:value>N</sdc:value></sdc:i_STATUS_MMC><sdc:i_STGVAL><sdc:value>0.00000</sdc:value></sdc:i_STGVAL><sdc:i_TERMFEE><sdc:value>1.00000</sdc:value></sdc:i_TERMFEE><sdc:i_TFEEPCT><sdc:value>100.00000</sdc:value></sdc:i_TFEEPCT><sdc:i_TFEETOT><sdc:value>1.00000</sdc:value></sdc:i_TFEETOT><sdc:i_TTERMFEE><sdc:value>1.00000</sdc:value></sdc:i_TTERMFEE><sdc:i_VALLIA><sdc:value>1.00000</sdc:value></sdc:i_VALLIA><sdc:i_VALNOLIA><sdc:value>0.00000</sdc:value></sdc:i_VALNOLIA><sdc:i_VALUE><sdc:value>1.00000</sdc:value></sdc:i_VALUE><sdc:j_EQVALCF><sdc:value>0.00000</sdc:value></sdc:j_EQVALCF><sdc:j_EVCF><sdc:value>0.00000</sdc:value></sdc:j_EVCF><sdc:j_EVEBIT><sdc:value>0.00000</sdc:value></sdc:j_EVEBIT><sdc:j_EVNI><sdc:value>0.00000</sdc:value></sdc:j_EVNI><sdc:j_EVSALES><sdc:value>0.00000</sdc:value></sdc:j_EVSALES><sdc:j_MPRICEBOOK><sdc:value>0.00000</sdc:value></sdc:j_MPRICEBOOK><sdc:j_PHELD><sdc:value>0.00000</sdc:value></sdc:j_PHELD><sdc:j_PSOUGHT><sdc:value>10.00000</sdc:value></sdc:j_PSOUGHT><sdc:j_RANKVALCF><sdc:value>0.00000</sdc:value></sdc:j_RANKVALCF><sdc:j_RANKVALEB><sdc:value>0.00000</sdc:value></sdc:j_RANKVALEB><sdc:j_RANKVALNA><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNA><sdc:j_RANKVALNI><sdc:value>0.00000</sdc:value></sdc:j_RANKVALNI><sdc:j_RANKVALSALES><sdc:value>0.00000</sdc:value></sdc:j_RANKVALSALES><sdc:j_VALEB><sdc:value>0.00000</sdc:value></sdc:j_VALEB><sdc:j_VALNI><sdc:value>0.00000</sdc:value></sdc:j_VALNI><sdc:j_VALSALES><sdc:value>0.00000</sdc:value></sdc:j_VALSALES><sdc:m_AMV><sdc:value>0.00000</sdc:value></sdc:m_AMV><sdc:m_CF3YGR><sdc:value>0.00000</sdc:value></sdc:m_CF3YGR><sdc:m_CF5YGR><sdc:value>0.00000</sdc:value></sdc:m_CF5YGR><sdc:m_DCR><sdc:value>0.00000</sdc:value></sdc:m_DCR><sdc:m_ENTVAL><sdc:value>0.00000</sdc:value></sdc:m_ENTVAL><sdc:m_EPS3YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS3YGR><sdc:m_EPS5YGR><sdc:value>0.00000</sdc:value></sdc:m_EPS5YGR><sdc:m_LTD><sdc:value>0.00000</sdc:value></sdc:m_LTD><sdc:m_MV><sdc:value>0.00000</sdc:value></sdc:m_MV><sdc:m_NETASS><sdc:value>0.00000</sdc:value></sdc:m_NETASS><sdc:m_NETASS3YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS3YGR><sdc:m_NETASS5YGR><sdc:value>0.00000</sdc:value></sdc:m_NETASS5YGR><sdc:m_NI3YGR><sdc:value>0.00000</sdc:value></sdc:m_NI3YGR><sdc:m_NI5YGR><sdc:value>0.00000</sdc:value></sdc:m_NI5YGR><sdc:n_SEQ><sdc:value sdc:p="0">1.00000</sdc:value><sdc:value sdc:p="1">2.00000</sdc:value><sdc:value sdc:p="2">3.00000</sdc:value><sdc:value sdc:p="3">4.00000</sdc:value><sdc:value sdc:p="4">5.00000</sdc:value><sdc:value sdc:p="5">6.00000</sdc:value><sdc:value sdc:p="6">7.00000</sdc:value><sdc:value sdc:p="7">8.00000</sdc:value></sdc:n_SEQ><sdc:n_SYNOPSIS><sdc:value sdc:p="0">BULGARIA - Finance Consulting</sdc:value><sdc:value sdc:p="1">Co acquired a 10% stake, or</sdc:value><sdc:value sdc:p="2">13.2 mil ordinary shares, in</sdc:value><sdc:value sdc:p="3">Sopharma JSC, a Sofia-based</sdc:value><sdc:value sdc:p="4">manufacturer of pharmaceutical</sdc:value><sdc:value sdc:p="5">products, from Telso AD, in an</sdc:value><sdc:value sdc:p="6">open market transaction. Terms</sdc:value><sdc:value sdc:p="7">were not disclosed.</sdc:value></sdc:n_SYNOPSIS><sdc:n_synopsis2><sdc:value>BULGARIA - Finance Consulting Co acquired a 10% stake, or 13.2 mil ordinary shares, in Sopharma JSC, a Sofia-based manufacturer of pharmaceutical products, from Telso AD, in an open market transaction. Terms were not disclosed.</sdc:value></sdc:n_synopsis2><sdc:n_synopsis3><sdc:value sdc:p="0">BULGARIA - Finance Consulting Co acquired a 10% stake, or 13.2 mil ordinary shares, in</sdc:value><sdc:value sdc:p="1">Sopharma JSC, a Sofia-based manufacturer of pharmaceutical products, from Telso AD, in an</sdc:value><sdc:value sdc:p="2">open market transaction. Terms were not disclosed.</sdc:value></sdc:n_synopsis3><sdc:n_synopsis4><sdc:value sdc:p="0">BULGARIA - Finance Consulting Co acquired a 10% stake, or 13.2 mil ordinary shares, in Sopharma JSC, a Sofia-based manufacturer of pharmaceutical products, from Telso AD, in an open market</sdc:value><sdc:value sdc:p="1">transaction. Terms were not disclosed.</sdc:value></sdc:n_synopsis4><sdc:n_synopsis5><sdc:value sdc:p="0">BULGARIA - Finance Consulting Co acquired a 10% stake, or 13.2 mil ordinary shares, in Sopharma JSC, a Sofia-based manufacturer of</sdc:value><sdc:value sdc:p="1">pharmaceutical products, from Telso AD, in an open market transaction. Terms were not disclosed.</sdc:value></sdc:n_synopsis5><sdc:q_DESCR><sdc:value>Completed</sdc:value></sdc:q_DESCR><sdc:q_HOSTANETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTANETASS><sdc:q_HOSTANILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTANILTM><sdc:q_HOSTASALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTASALESLTM><sdc:q_HOSTATASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTATASS><sdc:q_HOSTBOOKVALUE><sdc:value>0.00000</sdc:value></sdc:q_HOSTBOOKVALUE><sdc:q_HOSTCASHFLOW><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW><sdc:q_HOSTCASHFLOW1><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW1><sdc:q_HOSTCASHFLOW2><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW2><sdc:q_HOSTCASHFLOW3><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW3><sdc:q_HOSTCASHFLOW4><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW4><sdc:q_HOSTCASHFLOW5><sdc:value>0.00000</sdc:value></sdc:q_HOSTCASHFLOW5><sdc:q_HOSTCOMMONEQUITY><sdc:value>0.00000</sdc:value></sdc:q_HOSTCOMMONEQUITY><sdc:q_HOSTEBITLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEBITLTM><sdc:q_HOSTEPS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS1><sdc:q_HOSTEPS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS2><sdc:q_HOSTEPS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS3><sdc:q_HOSTEPS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS4><sdc:q_HOSTEPS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPS5><sdc:q_HOSTEPSLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTEPSLTM><sdc:q_HOSTNETASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS><sdc:q_HOSTNETASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS1><sdc:q_HOSTNETASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS2><sdc:q_HOSTNETASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS3><sdc:q_HOSTNETASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS4><sdc:q_HOSTNETASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNETASS5><sdc:q_HOSTNI1><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI1><sdc:q_HOSTNI2><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI2><sdc:q_HOSTNI3><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI3><sdc:q_HOSTNI4><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI4><sdc:q_HOSTNI5><sdc:value>0.00000</sdc:value></sdc:q_HOSTNI5><sdc:q_HOSTNILTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTNILTM><sdc:q_HOSTPTINC1><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC1><sdc:q_HOSTPTINC2><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC2><sdc:q_HOSTPTINC3><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC3><sdc:q_HOSTPTINC4><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC4><sdc:q_HOSTPTINC5><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINC5><sdc:q_HOSTPTINCLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTPTINCLTM><sdc:q_HOSTSALES1><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES1><sdc:q_HOSTSALES2><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES2><sdc:q_HOSTSALES3><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES3><sdc:q_HOSTSALES4><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES4><sdc:q_HOSTSALES5><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALES5><sdc:q_HOSTSALESLTM><sdc:value>0.00000</sdc:value></sdc:q_HOSTSALESLTM><sdc:q_HOSTTASS><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS><sdc:q_HOSTTASS1><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS1><sdc:q_HOSTTASS2><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS2><sdc:q_HOSTTASS3><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS3><sdc:q_HOSTTASS4><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS4><sdc:q_HOSTTASS5><sdc:value>0.00000</sdc:value></sdc:q_HOSTTASS5><sdc:q_STATUS><sdc:value>Status:Completed</sdc:value></sdc:q_STATUS><sdc:r_PE><sdc:value>-999.00000</sdc:value></sdc:r_PE><sdc:r_PE_PRINT><sdc:value>np</sdc:value></sdc:r_PE_PRINT><sdc:r_PFTMARG><sdc:value>0.00000</sdc:value></sdc:r_PFTMARG><sdc:r_PRICEBOOK><sdc:value>-999.00000</sdc:value></sdc:r_PRICEBOOK><sdc:r_PRICEBOOK_PRINT><sdc:value>np</sdc:value></sdc:r_PRICEBOOK_PRINT><sdc:r_PTINC3YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC3YGR><sdc:r_PTINC5YGR><sdc:value>0.00000</sdc:value></sdc:r_PTINC5YGR><sdc:r_ROE><sdc:value>0.00000</sdc:value></sdc:r_ROE><sdc:r_SALES3YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES3YGR><sdc:r_SALES5YGR><sdc:value>0.00000</sdc:value></sdc:r_SALES5YGR><sdc:r_SE><sdc:value>0.00000</sdc:value></sdc:r_SE><sdc:r_TASS3YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS3YGR><sdc:r_TASS5YGR><sdc:value>0.00000</sdc:value></sdc:r_TASS5YGR><sdc:r_TTCFMULT><sdc:value>0.00000</sdc:value></sdc:r_TTCFMULT><sdc:r_TTEBITMULT><sdc:value>0.00000</sdc:value></sdc:r_TTEBITMULT><sdc:r_VALNA><sdc:value>0.00000</sdc:value></sdc:r_VALNA><sdc:sic_SIC><sdc:value sdc:p="0">2833:Medicinal chemicals and botanical products</sdc:value><sdc:value sdc:p="1">2834:Pharmaceutical preparations</sdc:value><sdc:value sdc:p="2">2836:Biological products, except diagnostic substances</sdc:value></sdc:sic_SIC><sdc:upa_UPACIDGEN><sdc:value>75013001</sdc:value></sdc:upa_UPACIDGEN><sdc:upa1_NATION><sdc:value>Bulgaria</sdc:value></sdc:upa1_NATION><sdc:upa1_SICP><sdc:value>6282</sdc:value></sdc:upa1_SICP><sdc:upa1_STATE><sdc:value>Foreign</sdc:value></sdc:upa1_STATE><sdc:upa1_STATUS><sdc:value>Private</sdc:value></sdc:upa1_STATUS><sdc:upsic_SIC><sdc:value sdc:p="0">2833:Medicinal chemicals and botanical products</sdc:value><sdc:value sdc:p="1">2834:Pharmaceutical preparations</sdc:value><sdc:value sdc:p="2">2836:Biological products, except diagnostic substances</sdc:value></sdc:upsic_SIC><sdc:upt_UPTCIDGEN><sdc:value>540804003</sdc:value></sdc:upt_UPTCIDGEN><sdc:upt1_EXCHANGE><sdc:value>Sofia</sdc:value></sdc:upt1_EXCHANGE><sdc:upt1_NATION><sdc:value>Bulgaria</sdc:value></sdc:upt1_NATION><sdc:upt1_SICP><sdc:value>2834</sdc:value></sdc:upt1_SICP><sdc:upt1_STATE><sdc:value>Foreign</sdc:value></sdc:upt1_STATE><sdc:upt1_STATUS><sdc:value>Public</sdc:value></sdc:upt1_STATUS><sdc:upt1_TICKER><sdc:value>SFARM</sdc:value></sdc:upt1_TICKER><sdc:x_RANK1_VALUE><sdc:value>1.00000</sdc:value></sdc:x_RANK1_VALUE><sdc:x_RANK_HOSTRANKVAL><sdc:value>1.00000</sdc:value></sdc:x_RANK_HOSTRANKVAL><sdc:x_RANK_RANKVAL><sdc:value>1.00000</sdc:value></sdc:x_RANK_RANKVAL><sdc:x_rank_rankstgval><sdc:value>0.53500</sdc:value></sdc:x_rank_rankstgval></sdc:deal><category>Deal Information</category><alacra:ip>Thomson Financial Mergers &amp; Acquisitions</alacra:ip></item><item><link>http://www.alacrastore.com/storecontent/bir/450620</link><guid isPermaLink="false">bir/450620</guid><bir:index_mode xmlns:bir="http://www.alacra.com/bir">norm</bir:index_mode><title>Sopharma AD</title><bir:company xmlns:bir="http://www.alacra.com/bir">Sopharma AD</bir:company><bir:cou xmlns:bir="http://www.alacra.com/bir">Bulgaria</bir:cou><bir:descr xmlns:bir="http://www.alacra.com/bir">Manufacturing: Research, manufacture, and trade in proprietary pharmaceutical substances, phytochemical products and finished drug forms</bir:descr><bir:sic xmlns:bir="http://www.alacra.com/bir">2834</bir:sic><bir:ssic xmlns:bir="http://www.alacra.com/bir">2833</bir:ssic><bir:ssic xmlns:bir="http://www.alacra.com/bir">2836</bir:ssic><bir:naics xmlns:bir="http://www.alacra.com/bir">325412</bir:naics><bir:snaics xmlns:bir="http://www.alacra.com/bir">325411</bir:snaics><bir:snaics xmlns:bir="http://www.alacra.com/bir">325414</bir:snaics><bir:class xmlns:bir="http://www.alacra.com/bir">9</bir:class><bir:size xmlns:bir="http://www.alacra.com/bir">F</bir:size><bir:revenue xmlns:bir="http://www.alacra.com/bir">H</bir:revenue><bir:ticker xmlns:bir="http://www.alacra.com/bir">SFARM</bir:ticker><pubDate>6/21/2008 6:44:38 AM</pubDate><bir:docid xmlns:bir="http://www.alacra.com/bir">450620</bir:docid><category>Company Profiles &amp; Financials</category><alacra:ip>Gale Company Profiles</alacra:ip></item></channel></rss>